BRUNI, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.620
AS - Asia 4.297
EU - Europa 1.577
SA - Sud America 624
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 73
OC - Oceania 7
Totale 11.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.392
CN - Cina 1.331
SG - Singapore 1.145
IT - Italia 703
VN - Vietnam 502
BR - Brasile 471
HK - Hong Kong 368
BD - Bangladesh 282
KR - Corea 222
GB - Regno Unito 184
TR - Turchia 162
FI - Finlandia 133
CA - Canada 108
DE - Germania 100
SE - Svezia 88
FR - Francia 79
IN - India 64
ID - Indonesia 58
MX - Messico 55
AR - Argentina 51
RU - Federazione Russa 45
UA - Ucraina 44
NL - Olanda 36
CO - Colombia 28
ES - Italia 28
BG - Bulgaria 26
IQ - Iraq 25
JP - Giappone 25
EC - Ecuador 21
BE - Belgio 20
CL - Cile 19
PL - Polonia 19
ZA - Sudafrica 17
PK - Pakistan 15
MY - Malesia 14
AE - Emirati Arabi Uniti 13
IE - Irlanda 12
VE - Venezuela 12
CR - Costa Rica 11
DZ - Algeria 10
PY - Paraguay 10
EG - Egitto 9
SA - Arabia Saudita 9
KE - Kenya 8
LT - Lituania 8
HN - Honduras 7
JM - Giamaica 7
NP - Nepal 7
PE - Perù 7
AL - Albania 6
AU - Australia 6
IL - Israele 6
PH - Filippine 6
RO - Romania 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
JO - Giordania 5
PA - Panama 5
SV - El Salvador 5
AT - Austria 4
BZ - Belize 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
IR - Iran 4
MA - Marocco 4
QA - Qatar 4
RS - Serbia 4
UZ - Uzbekistan 4
BO - Bolivia 3
DK - Danimarca 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NI - Nicaragua 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
TG - Togo 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CH - Svizzera 2
CY - Cipro 2
EE - Estonia 2
HT - Haiti 2
MQ - Martinica 2
PR - Porto Rico 2
SI - Slovenia 2
TW - Taiwan 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 11.177
Salva come PNG Salva come JPEG
Città #
Hefei 779
Ashburn 668
Singapore 640
San Jose 445
Hong Kong 358
Council Bluffs 357
Santa Clara 295
Seoul 222
Fairfield 213
Ho Chi Minh City 169
Istanbul 130
Hanoi 126
Beijing 125
Los Angeles 123
Helsinki 121
Houston 94
New York 88
Wilmington 80
Milan 79
Chandler 76
Woodbridge 76
London 75
Seattle 75
Chicago 71
Boardman 66
Shanghai 66
Lauterbourg 64
Cambridge 63
Buffalo 61
Dallas 57
Modena 53
Rome 49
Kent 46
Southend 41
Nyköping 38
São Paulo 38
The Dalles 36
Phoenix 32
Mexico City 30
Naples 30
Orem 30
Salt Lake City 28
Montreal 27
Ann Arbor 25
Da Nang 24
Jakarta 24
Princeton 22
San Diego 22
Bologna 21
Sofia 21
Turin 21
Dearborn 20
Frankfurt am Main 19
Haiphong 19
Tokyo 19
Toronto 19
Brooklyn 17
Jacksonville 17
Warsaw 17
Atlanta 16
Denver 16
Chennai 14
Dhaka 14
Florence 14
Leuven 14
Munich 14
Reggio Emilia 14
Biên Hòa 13
Las Vegas 13
Miami 13
Elk Grove Village 12
Johannesburg 12
Lappeenranta 12
Rio de Janeiro 12
San Francisco 12
Washington 12
Baghdad 11
Eugene 11
Nuremberg 11
Osasco 11
Poplar 11
Tampa 11
Brasília 10
Izmir 10
Palermo 10
Santiago 10
Shenzhen 10
Brescia 9
Charlotte 9
Columbus 9
Curitiba 9
Guangzhou 9
Manchester 9
Moscow 9
Portsmouth 9
Ankara 8
Dublin 8
Miano 8
New Orleans 8
San José 8
Totale 7.122
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 362
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 335
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 311
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 290
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 285
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 264
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 234
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 222
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 220
Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy 206
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 200
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 191
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 174
Lattice Radiation Therapy in clinical practice: A systematic review 173
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients 167
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 165
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 163
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 162
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study 161
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 160
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis 157
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 156
Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation 155
Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial 148
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 146
Current radiotherapy techniques in NSCLC: challenges and potential solutions 146
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 146
The role of postoperative radiotherapy for thymomas: a multicentric retrosepective evaluation from three Italian centers and review of the literature. 142
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 137
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 136
A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC 134
Guidelines on prostate carcinoma - AIRO, 2016 133
Quality of life after prostate cancer diagnosis: Data from the Pros-IT CNR 133
Erratum: The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature (Journal of Thoracic Disease (2020) 12 (7518-7530) DOI: 10.21037/jtd-2019-thym-09) 131
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 130
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 128
Non-invasive approach to treat primary solid solitary pulmonary nodule: a narrative review by the radiation oncologist perspective 126
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 122
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 122
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 121
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo) 119
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 118
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 117
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 116
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 115
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 113
Response to Letter to the Editor Titled “Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?” 112
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 110
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 110
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 110
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 109
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 108
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach 107
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 105
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance 104
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 103
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 102
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 102
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 101
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 99
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 99
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 96
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 96
Brain metastases from primary colorectal cancer: Is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 94
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 91
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 87
Reirradiation in head and neck recurrent or second primary tumor: Efficacy, safety, and prognostic factors 85
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 84
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer 82
Management of Stage II testicular seminoma over a period of 40 years 81
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: The impact of thoracic and brain irradiation on survival 81
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients 80
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 79
Radiation therapy in small cell lung cancer: a national Italian survey 79
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 79
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 76
Oral ibandronate in metastatic bone breast cancer: The Florence University experience and a review of the literature 75
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: A retrospective analysis 74
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 70
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 62
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 56
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study 56
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 56
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial 51
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 23
Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices 19
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial 19
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study 10
Totale 11.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022306 0 0 0 15 14 25 27 31 39 31 93 31
2022/2023294 38 37 40 15 40 31 5 20 40 2 10 16
2023/2024257 18 13 24 31 21 12 22 40 8 15 15 38
2024/20251.715 30 2 17 62 158 133 46 78 171 314 355 349
2025/20266.383 505 406 702 791 607 406 609 305 662 457 491 442
2026/20271.500 241 450 386 423 0 0 0 0 0 0 0 0
Totale 11.314